My Blog

Blog

  • z21 ventures announces investment in FlashAid, a healthcare technology platform democratizing healthcare for masses in India

    z21 ventures announces investment in FlashAid, a healthcare technology platform democratizing healthcare for masses in India

     

    FlashAid is democratizing healthcare coverage by offering affordable health coverage to millions in India. It offers a unique membership plan that covers hospitalization expenses and Primary benefits such as teleconsultation, labs, diagnostics, and home care services. FlashAid is a healthcare technology platform that partners with various healthcare service providers to bring the best care you deserve at an affordable price.

     

    The retail health insurance market is one of the fastest growing segments with a CAGR of 18% and is expected to touch $25B by 2028. Founded by Manoj Gupta and Gunjali Kothari, FlashAid is working on exclusive tie-ups with insurance companies to tailor-make products and partner with e-commerce platforms and brands to distribute insurance to their users. The company offers a full-stack health solution with proprietary pre-underwritten products, open APIs, and embedded solutions.

     

    ” With an expected 30% surge in digital platform adoption by 2030, a significant opportunity emerges to align the ecosystem towards providing scalable solutions that promote health equity in India. We’re actively embracing this digital evolution through our API-centric strategy, which resonates with customers’ shifting behaviors in purchasing and accessing healthcare services. This approach aims to make the healthcare ecosystem more accessible and user-friendly, benefiting the wider population”. – Manoj Gupta | Founder & CEO, FlashAid

     

    Its distributive technology has made traditional retail Insurance cheaper by 70% and solves complex onboarding and tedious claim processing. With personal retail Health Insurance penetration of less than 4% in India, FlashAid ‘s unique B2B2C distribution approach makes it highly scalable, keeping the acquisition cost low. Within just 1 year of launch, they have 30,000+ lives already on board and are expected to cross 100K lives in another 6 months.

     

    z21 ventures is excited to announce our investment in FlashAid. Its scalable embedded insurance product with a comprehensive healthcare offering provides a unique value proposition for expanding the healthcare insurance market globally. 

  • z21 ventures announces investment in vHub, an AI-driven SaaS platform revolutionizing the influencer marketing industry

    z21 ventures announces investment in vHub, an AI-driven SaaS platform revolutionizing the influencer marketing industry

     

    The influencer marketing industry, currently valued at $13.8 billion globally, is projected to grow exponentially. However, brands and enterprises are still challenged with influencer discovery, navigating influencer authenticity, and optimizing the ROI of influencer marketing campaigns.

     

    vHub.ai is revolutionizing the influencer marketing industry by making it more data-driven and insightful. Founded in 2021, the company’s AI-driven SaaS platform empowers brands and advertisers with deeper insights into their target audiences on platforms like Instagram, YouTube, and LinkedIn. It provides tools for easily discovering the right content creators and effective strategies, enabling brands to optimize and precisely target their visibility on these social media platforms.

     

    z21 ventures is pleased to announce our strategic investment in vHub.ai. This investment reflects our commitment to supporting innovative AI-driven SaaS platforms. vHub.ai’s offerings include an AI-powered influencer discovery engine, fraud detection tools, a detailed ROI dashboard, a comprehensive influencer marketing campaign management suite, a marketplace for brands and influencers to connect, and an audience dashboard for brands to analyze their presence on social media platforms.

     

    “Partnering with z21 Ventures has validated our vision and fueled our growth, providing capital and access to invaluable advice from a supportive community of mentors and industry leaders. z21 is also instrumental in enhancing our Go-To-Market strategy and connecting us with expert advisors, further driving our innovations in influencer marketing.”- Sachin Modi | Co-founder & CEO of vHub.AI

     

    We are excited about the investment and collaboration with vHub.ai and the z21 community, and we look forward to working closely with the vHub.ai team to propel them toward even greater heights.

  • z21 ventures announces investment in CoverSelf, a healthcare-specific, next-gen, cloud-native, and customizable claims accuracy platform.

    z21 ventures announces investment in CoverSelf, a healthcare-specific, next-gen, cloud-native, and customizable claims accuracy platform.

     

    The complex US healthcare system is wasting hundreds of millions of dollars on bureaucracy because of poor data and a lack of transparency. Administrative expenses account for almost a quarter of the $4.1 trillion spent on healthcare in the US each year. Improvements in automated claims processing, data accuracy, and transparency could therefore release huge savings for providers and payers alike, freeing up cash to fund healthcare improvements.

     

    CoverSelf’s healthcare-specific, next-gen, cloud-native, and customizable claims accuracy platform is built from the ground up using modern software development techniques. It empowers users’ long-term success by smoothly adapting to ever-evolving, dynamic claims, and payment inaccuracies, reducing complexities and administrative costs.

     

    z21 Ventures is pleased to announce our strategic investment in CoverSelf. This investment reflects our commitment to supporting innovative solutions and purposeful companies that reshape healthcare IT. CoverSelf aligns seamlessly with our vision, providing an innovative payment integrity solution that addresses payment leakage and claims inaccuracies while remaining transparent and accessible to payers.

     

    “The team and community has hands-on business experience, deep understanding of healthcare and enterprise software, and extensive industry connections make them invaluable assets for startups seeking more than just funding.” – Rajasekhar Maddireddy | Founder & CEO of Coverself

     

    We are excited about the investment and collaboration with CoverSelf and the z21 community, and we look forward to working closely with the CoverSelf team to propel them toward even greater heights. 

  • Announcing our investment in Zime, AI-first sales content and training

    Announcing our investment in Zime, AI-first sales content and training

     

    Sales cycles can be complex and as reps spend time on several pieces of fragmented content, training, and unstructured information, Zime AI distills all these into a unified taxonomy of actions for sellers and win-loss insights for marketing and revenue teams. 

    At z21, we are excited about our partnership with Zime, to supercharge sellers with valuable insights and just-in-time actions and help them close more deals and do that faster. By bringing the power of Gen AI and behavioral science, we believe sales performance can be tangibly enhanced with Zime’s disruption solution.


    Zime AI is powered by company-specific sales data, and generates personalized content, replacing traditional training and providing strategic insights from numerous customer interactions. We envision a future where sales teams are armed with actionable intelligence, unique to their sales cycles, products & markets.

     

     “Building a company needs a village. To supercharge my growth, I was looking for investors who have been SaaS operators and have built large companies. I loved every interaction with the z21 team & how they are helping us think ahead.” – Sanchit Garg, Founder & CEO, Zime

     

    We are excited about the investment in Zime and we look forward to working closely with the Zime team to propel them toward even greater heights.

  • Announcing z21 Ventures investment in Meomind, the scalable alternative to psychotherapy

    Announcing z21 Ventures investment in Meomind, the scalable alternative to psychotherapy

     

    Outpatient psychotherapy is a $50Bn global market and $25Bn+ is spent on outpatient mental therapy every year in the US. Despite a widespread, growing, and acute need for therapy solutions, there isn’t a single one that is accessible in a timely way, affordable, and effective in driving clinical outcomes. Users need to wait for weeks to get in touch with a therapist who may or may not be the right fit for them. This significantly delays the process of seeking help and worsens the symptoms for many users. 

     

    z21 Ventures is pleased to announce our strategic investment in Meomind. By uniquely creating a vast library of pre-recorded therapy sessions, Meomind is on the path to providing on-demand access to high-quality relatable solutions to millions of users. With 70k+ members on the platform, 80% of members have reported feeling better in 2.5 weeks. This makes Meomind a great benefit that employers and health plans can offer to support the mental well-being of members.

     

    This partnership is a testament to our belief in the role of technology to make effective mental well-being solutions accessible to all. Meomind partners with world-class therapists to curate therapy sessions relatable to diverse scenarios.

     

    “The entire z21 team has been incredibly helpful in connecting us to a rich network of GTM experts, technologists, and investors. z21 has built a unique value proposition with the vast reach of its LPs who not only have deep expertise but are also very generous with their time and advice.” – Sushant Gupta, CEO, Meomind

     

    We look forward to working closely with Sushant and the Meomind team to disrupt the mental health landscape.

  • Announcing z21 Ventures investment in Rexera (formerly InspectHOA), an AI-powered solution for streamlining real estate closings.

    Announcing z21 Ventures investment in Rexera (formerly InspectHOA), an AI-powered solution for streamlining real estate closings.

     

    Rexera, formerly InspectHOA, is a leading provider of HOA documents acquisition and modernized settlement processes for the real estate industry. It is known for its flagship HOA service, which helps title and escrow companies, underwriters, real estate attorneys, mortgage lenders, and investors avoid the difficulties that come with dealing directly with HOAs in the closing process. 

     

    Using a combination of the largest database in the country, AI technology, and HOA professionals, Rexera offers HOA and condo documents acquisition and analysis services, municipal lien search, mortgage payoff, and asset management solutions which lead to faster closing times, seamless asset management, lower error rates, higher customer satisfaction, and employee engagement.

     

    z21 Ventures is pleased to announce our strategic investment in Rexera. This partnership reflects our commitment to supporting innovative solutions that reshape the future of work. Rexera aligns seamlessly with our vision, providing innovative, reliable, and inclusive services that revolutionize the real estate market. Rexera’s AI Co-pilot has the potential to transform the real estate closing process and reduce the time-to-close. 

     

    We are excited about the positive impact this collaboration will bring, and we look forward to working closely with the Rexera team to propel them toward even greater heights. Together, we embark on a journey of accelerating real estate workflows.

  • Announcing z21 Ventures investment in Develo, the modern operating system for pediatrics

    Announcing z21 Ventures investment in Develo, the modern operating system for pediatrics

     

    Despite annual spending of $410B+ for ~113M patients annually in the United States, traditional electronic medical record (EMR) systems overlook the uniquely family-centered, relationship-driven, and high-volume nature of outpatient pediatric care. The adult-first approach of legacy systems significantly impacts practice performance, with many facing patient throughput and claim denials challenges. Rising value-based care, consumerism, and regulatory headwinds add more pressure on independent practices to modernize their technology stack– but traditional EMRs lack the foundations to meet those emerging needs.

     

    Develo sets the new standard for pediatric software tailor built for independent pediatric practices.

     

    z21 Ventures is pleased to announce our strategic investment in Develo. By uniquely combining EMR and customer relationship management (CRM) capabilities, Develo boosts practice net revenues by 20% and saves ~10 hours a week per practice user. Standout features such as charge capture automation, AI-enabled clinical documentation, automated family outreach, and pediatrics task management significantly improve practice productivity and family satisfaction with their care.

     

    This partnership reflects our deep belief in the role of modern technology in driving transformative, world-class experiences for pediatricians, patients, and their families. Develo is not just a better pediatric EMR, but the first end-to-end operating system for pediatrics. FHIR-native interoperability and frictionless e-fax, e-prescribe, and e-lab integration foundations have real potential to future-proof pediatric practices.

     

    We look forward to working closely with the Develo team on their journey to disrupt pediatric care and improve child health.

  • Announcing z21 Ventures Investment in Gloroots, an all-in-one solution to help discover, onboard, and manage employees globally.

    Announcing z21 Ventures Investment in Gloroots, an all-in-one solution to help discover, onboard, and manage employees globally.

     

    As the global business landscape evolves, the challenges of international workforce management persist. Despite remarkable strides, businesses grapple with complexities in engaging global talent seamlessly. Gloroots addresses this need by facilitating frictionless engagement and onboarding of global talent. In today’s dynamic environment, the demand for remote work and cross-border collaborations is burgeoning. Gloroots, with its innovative solutions, empowers businesses to transcend geographical constraints, tapping into a diverse pool of talent worldwide. The platform adeptly navigates compliance intricacies and local labor laws, ensuring a secure and streamlined international employment experience.

     

    z21 Ventures is pleased to announce our strategic investment in Gloroots. This partnership reflects our commitment to supporting innovative solutions that reshape the future of work. Gloroots aligns seamlessly with our vision, providing accessible, affordable, and inclusive services that bridge the gap for businesses seeking to harness global talent. In a world where talent knows no borders, Gloroots shines as a north star, facilitating a borderless employment landscape.

     

    We are excited about the positive impact this collaboration will bring, and we look forward to working closely with the Gloroots team to propel them toward even greater heights. Together, we embark on a journey of innovation, inclusivity, and global workforce transformation.

  • Announcing z21 Ventures Investment in earKART, a healthcare technology company specializing in smart diagnosis and remote management of hearing aids

    Announcing z21 Ventures Investment in earKART, a healthcare technology company specializing in smart diagnosis and remote management of hearing aids

     

    z21 Ventures is pleased to announce our investment in earKART serving the vast patient population in India struggling with hearing loss. This issue affects nearly 98.5 million people across the nation, with an alarming statistic that over 60% of them lack access to essential audiological services. earKART has set out to change this narrative by offering cutting-edge hearing aids at affordable prices, ensuring that quality hearing care is accessible to all.

     

    earKART has built a unique approach to audiology, exemplified by its smart diagnosis and remote management services. By leveraging technology, patients can now enjoy the latest audiological advancements from the comfort of their homes, thus redefining the landscape of hearing care in India. The audiology market has exhibited consistent growth, averaging between 7-8% per year. With earKART’s unique model, they can bring an additional growth of 5-7% within just three years, further fueling the expansion of audiological services in India.

     

    The company has recently applied for a patent that merges medical device diagnostics with remote computing, setting the stage for the world’s first remote diagnosis and remote programming audiology model. This innovation holds the potential to revolutionize the industry and provide patients with a more convenient and efficient hearing care experience. In addition to its successful online platform, earKART also boasts India’s largest all-brand hearing clinic network, comprising over 1,250 clinics. earKART is gearing up to launch feature-rich, affordable hearing aids by the end of 2023 and has initiated the manufacture of economy-model hearing aids within India. Moreover, they are preparing to implement their remote audiometry and remote-hearing aid programming model through 1,500 ENT doctors and optical clinics, further enhancing their reach and impact in the field of audiology.

     

    At z21 Ventures, we are excited to partner with earKART who are not only reshaping the audiological landscape in India but also promising a brighter future for countless individuals in need of hearing support.

  • Announcing z21 Ventures investment in Perceptyne, a revolutionary AI and Robotics company automating the dexterous tasks scalably

    Announcing z21 Ventures investment in Perceptyne, a revolutionary AI and Robotics company automating the dexterous tasks scalably

     

    Advancements in robotics, artificial intelligence (AI), and machine learning have paved the way for a new era of automation. Startups like Boston Dynamics are leveraging these cutting-edge technologies to create robots capable of performing tasks that were once considered repetitive or dangerous for humans. Existing robots have proven quite successful in automating some of the precision tasks such as automated welding and e-commerce order sorting. However, they have significant limitations while handling complex & dexterous tasks, which constitute most of the un-automated tasks in industries today. Some examples of these dexterous tasks include product assembly (think smartphone assembly), eCommerce packing, mega kitchen operations (think dishwashing), etc.

     

    z21 ventures is pleased to announce our investment in Perceptyne, a revolutionary AI and Robotics company who are building the missing pieces of technology to automate these dexterous tasks in a generalized & scalable manner. Perceptyne’s competitive edge lies in its innovative technology differentiators. These include the utilization of coordinated dual robotic arms with a strong emphasis on visual servo & force feedback, highly articulate end effectors equipped with tactile sensing capabilities & a low-code tele-operative AI-assisted training system.

     

    Currently, Perceptyne is actively collaborating with companies operating in the EMS, Automotive, and Airline-catering sectors. Their groundbreaking technology promises to redefine the future of automation, transcending the limitations of traditional industrial robots and opening new possibilities for a wide range of industries.

     

    Funding and support for deep-tech startups in India pale in comparison to the US. We believe that due to its world-class technology talent, India is poised to produce the next generation of deep-tech unicorns which will solve global problems through moonshot technology. Z21 is excited to partner with Perceptyne and we look forward to working closely with the Perceptyne team to help them achieve these goals.